Comorbidities are common in people living with Alzheimer’s disease (AD) where chronic comorbidities co-exist, such as diabetes and cardiovascular diseases. The relationship between comorbidity and AD is multifaceted, and causal relationships are difficult to disentangle.​​ This slide deck describes current knowledge on the the physical and psyciatric comorbidites of AD.

This slide deck has been developed by Janet Janbek, PhD, Danish Dementia Research Centre, Rigshospitalet, University of Copenhagen, Denmark; and Professor Serge Gauthier, McGill University, Montréal, Québec, Canada, in collaboration with Cambridge Medical – A Prime Global agency.

Index for
slide deck

Introduction

Comorbidities
Comorbidities
file_download Download slide in HQ

Introduction to Alzheimer’s disease comorbidities

Introduction to Alzheimer’s disease comorbidities
Introduction to Alzheimer’s disease comorbidities
file_download Download slide in HQ
Comorbidities are common in people living with Alzheimer’s disease
Comorbidities are common in people living with Alzheimer’s disease

Comorbidities are common in people living with AD where chronic comorbidities co-exist, such as diabetes and cardiovascular diseases.1,8-10 Patients with AD are also at risk for the occurrence of acute illnesses, such as infections and fractures.4,11 Apathy, irritability,…

file_download Download slide in HQ
An overview of comorbidities in Alzheimer’s disease – II
An overview of comorbidities in Alzheimer’s disease – II

Based on findings from a systematic literature review, patients with AD are more likely to have cardiovascular disease, including stroke than individuals without AD.1 In most studies, diabetes was slightly more common in patients with AD compared with controls, or prevale…

file_download Download slide in HQ

The physical comorbidities of Alzheimer’s disease

The physical comorbidities of Alzheimer’s disease
The physical comorbidities of Alzheimer’s disease
file_download Download slide in HQ
Vascular disease, cardiovascular disease, and Alzheimer’s disease
Vascular disease, cardiovascular disease, and Alzheimer’s disease

Several risk factors are associated with AD and cardiovascular disease (CVD).1 From a genetic standpoint, understanding the risk for AD is complex.1 The apolipoprotein (APOE) e4 allele has been identified as a risk factor for both AD and cardiovascular disease.1 Additiona…

file_download Download slide in HQ
Diabetes and Alzheimer’s disease
Diabetes and Alzheimer’s disease

Diabetes and AD may share risk factors, including overlapping metabolic risk factors. Apolipoprotein E (APOE) also regulates lipid metabolism.9 This suggests that the aetiology of AD includes metabolic risk factors, which are also involved in the development of diabetes.1…

file_download Download slide in HQ
Infections and Alzheimer’s disease
Infections and Alzheimer’s disease

Infectious diseases are suggested to increase the long-term risk of dementia, including AD.2 This is supported by research of hospital-treated infections, with evidence that infections occurring more than 10 years before the onset of dementia may also be associated with e…

file_download Download slide in HQ
Osteoporosis, falls, fractures, and Alzheimer’s disease
Osteoporosis, falls, fractures, and Alzheimer’s disease

Osteoporosis is defined as a skeletal disorder with compromised bone strength that increases the risk of fracture.6 Although osteoporosis and AD are two distinct diseases, several risk factors are shared between them, such as alcohol consumption and smoking.8,9 The associ…

file_download Download slide in HQ
Seizures, epilepsy, and Alzheimer’s disease
Seizures, epilepsy, and Alzheimer’s disease

AD and epilepsy in older adults are common diseases of the nervous system, with incidence rates increasing with age.2 Several studies have investigated the shared pathology and clinical relevance of AD and epilepsy.7-9 Additionally, the key pathology of AD – amyloid b (Ab…

file_download Download slide in HQ

Related content

The Challenges and Potential of Clinical Trials in Dementia Research play_circle Video play_circle
The Challenges and Potential of Clinical Trials in Dementia Research

Professor Dr. Matthew Kiernan discusses the limitations of current trial models.

12.11.2024 Alzheimer’s Disease
image Image Stroke, migraine, AD and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021
Highlights from the Global Burden of Disease 2021 Study

Stroke, migraine, Alzheimer’s Disease and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021

25.07.2024 Alzheimer’s Disease
description Article
Global perspectives on Alzheimer’s disease diagnosis and treatment: challenges and considerations in resource-limited settings

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease and the leading cause of dementia worldwide, regardless of socioeconomic status.

09.07.2024 Alzheimer’s Disease